Symbols / CERO Stock $0.03 -2.94% CERo Therapeutics Holdings, Inc.

Healthcare • Biotechnology • United States • OQB
CERO (Stock) Chart
About

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 696.39K
Enterprise Value 8.40M Income -49.19M Sales —
Book/sh -8.85 Cash/sh 0.09 Dividend Yield —
Payout 0.00% Employees 8 IPO —
P/E — Forward P/E -0.01 PEG —
P/S — P/B -0.00 P/C —
EV/EBITDA -0.49 EV/Sales — Quick Ratio 0.23
Current Ratio 0.30 Debt/Eq — LT Debt/Eq —
EPS (ttm) -2.27 EPS next Y -2.50 EPS Growth —
Revenue Growth — Earnings 2025-11-19 16:00 ROA -210.22%
ROE — ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 21.10M
Shs Float 19.97M Short Float 10.50% Short Ratio 0.83
Short Interest — 52W High 28.40 52W Low 0.03
Beta 0.24 Avg Volume 520.71K Volume 291.96K
Target Price — Recom Hold Prev Close $0.03
Price $0.03 Change -2.94%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.03
Latest analyst target
3. DCF / Fair value
$-6.70
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.03
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-18 down D. Boral Capital Buy → Hold —
2025-10-30 main D. Boral Capital Buy → Buy $30
2025-10-22 main D. Boral Capital Buy → Buy $30
2025-10-13 main D. Boral Capital Buy → Buy $30
2025-09-23 main D. Boral Capital Buy → Buy $30
2025-09-09 main D. Boral Capital Buy → Buy $30
2025-09-05 main D. Boral Capital Buy → Buy $30
2025-08-04 main D. Boral Capital Buy → Buy $30
2025-06-24 main D. Boral Capital Buy → Buy $30
2025-06-23 up D. Boral Capital Hold → Buy $30
2025-05-30 down D. Boral Capital Buy → Hold —
2025-05-19 init Maxim Group — → Buy $3
2025-04-25 main D. Boral Capital Buy → Buy $11
2025-04-23 main D. Boral Capital Buy → Buy $11
2025-04-22 init D. Boral Capital — → Buy $11
News
RSS: Latest CERO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-03-31 ATWOOD BRIAN G Director — 294,460 $0.00 $29
2024-12-13 YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 5,957,250 $0.06 $400,456
2024-12-10 YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 3,658,364 $0.09 $383,370
2024-10-10 YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 3,250,000 $0.10 $325,000
2024-09-25 LAPORTE KATHLEEN D Director — 965,997 — —
2024-09-25 ATWOOD BRIAN G Director — 19,358,578 — —
2024-09-25 EHRLICH CHRISTOPHER B Chief Executive Officer — 5,312,983 — —
2024-09-25 SLOAN STUART M Beneficial Owner of more than 10% of a Class of Security — 532,486 $0.10 $55,538
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
Operating Expense
7.68
-35.89%
11.97
+3.06%
11.62
Research And Development
5.29
-46.28%
9.85
+7.76%
9.14
Selling General And Administration
2.39
+12.27%
2.13
-14.27%
2.48
General And Administrative Expense
2.39
+12.27%
2.13
-14.27%
2.48
Other Gand A
2.39
+12.27%
2.13
-14.27%
2.48
Total Expenses
7.68
-35.89%
11.97
+3.06%
11.62
Operating Income
-7.68
+35.89%
-11.97
-3.06%
-11.62
Total Operating Income As Reported
-7.68
+35.89%
-11.97
-3.06%
-11.62
EBITDA
-6.56
+39.83%
-10.90
-0.16%
-10.88
Normalized EBITDA
-6.87
+36.99%
-10.90
-0.16%
-10.88
Reconciled Depreciation
1.12
+4.14%
1.07
+45.87%
0.74
EBIT
-7.68
+35.89%
-11.97
-3.06%
-11.62
Total Unusual Items
0.31
—
—
Total Unusual Items Excluding Goodwill
0.31
—
—
Special Income Charges
0.01
—
—
Other Special Charges
-0.01
—
—
Net Income
-7.29
+38.38%
-11.83
-11.28%
-10.63
Pretax Income
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Non Operating Interest Income Expense
0.14
-2.66%
0.14
-85.60%
0.99
Net Interest Income
0.14
-2.66%
0.14
-85.60%
0.99
Interest Income Non Operating
0.14
-2.66%
0.14
-85.60%
0.99
Interest Income
0.14
-2.66%
0.14
-85.60%
0.99
Other Income Expense
0.25
—
—
Other Non Operating Income Expenses
-0.06
—
—
Gain On Sale Of Security
0.30
—
—
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Income From Continuing Operation Net Minority Interest
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Income From Continuing And Discontinued Operation
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Income Continuous Operations
-7.29
+38.38%
-11.83
-11.28%
-10.63
Normalized Income
-7.60
+35.76%
-11.83
-11.28%
-10.63
Net Income Common Stockholders
-7.29
+38.38%
-11.83
-11.28%
-10.63
Otherunder Preferred Stock Dividend
0.00
—
—
Diluted EPS
-1,416.55
+45.74%
-2,610.71
-11.28%
-2,345.98
Basic EPS
-1,416.55
+45.74%
-2,610.71
-11.28%
-2,345.98
Basic Average Shares
0.01
+31.63%
0.00
+0.00%
0.00
Diluted Average Shares
0.01
+31.63%
0.00
+0.00%
0.00
Diluted NI Availto Com Stockholders
-7.29
+38.38%
-11.83
-11.28%
-10.63
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
6.21
+21.08%
5.13
-54.83%
11.35
-53.05%
24.18
Current Assets
3.71
+88.53%
1.97
-72.16%
7.08
-63.76%
19.52
Cash Cash Equivalents And Short Term Investments
3.33
+107.78%
1.60
-76.52%
6.82
-64.51%
19.22
Cash And Cash Equivalents
3.33
+107.78%
1.60
-76.52%
6.82
-64.51%
19.22
Cash Financial
3.33
+107.78%
1.60
-76.52%
6.82
-64.51%
19.22
Current Deferred Assets
0.11
0.00
—
—
Other Current Assets
0.27
-25.50%
0.37
+43.80%
0.26
-16.20%
0.31
Total Non Current Assets
2.49
-21.02%
3.16
-26.14%
4.27
-8.14%
4.65
Net PPE
1.99
-36.86%
3.16
-26.14%
4.27
-8.14%
4.65
Gross PPE
4.02
-15.29%
4.74
-12.16%
5.40
+1.84%
5.30
Accumulated Depreciation
-2.03
-27.60%
-1.59
-40.87%
-1.13
-73.17%
-0.65
Properties
—
—
0.00
0.00
Buildings And Improvements
—
—
2.85
-17.33%
3.44
Machinery Furniture Equipment
0.05
+0.00%
0.05
+0.00%
0.05
+75.12%
0.03
Other Properties
3.97
-15.44%
4.70
-12.26%
5.35
+1.47%
5.28
Non Current Deferred Assets
0.50
0.00
—
—
Total Liabilities Net Minority Interest
8.10
-82.83%
47.18
+2.09%
46.22
-2.91%
47.60
Current Liabilities
7.40
+111.07%
3.51
+201.31%
1.16
-36.68%
1.84
Payables And Accrued Expenses
6.26
+258.29%
1.75
+270.41%
0.47
-3.45%
0.49
Payables
4.67
+179.42%
1.67
+327.35%
0.39
-14.94%
0.46
Accounts Payable
4.51
+169.62%
1.67
+327.35%
0.39
-14.94%
0.46
Dividends Payable
0.09
0.00
—
—
Current Accrued Expenses
1.59
+1994.43%
0.08
-5.83%
0.08
+180.22%
0.03
Pensionand Other Post Retirement Benefit Plans Current
0.24
+255.62%
0.07
+247.69%
0.02
-97.41%
0.76
Total Tax Payable
0.08
0.00
—
—
Current Debt And Capital Lease Obligation
0.88
-35.97%
1.37
+103.57%
0.67
+14.89%
0.59
Current Debt
—
0.60
—
—
Current Capital Lease Obligation
0.88
+13.95%
0.77
+14.38%
0.67
+14.89%
0.59
Other Current Liabilities
0.02
-93.79%
0.32
—
—
Total Non Current Liabilities Net Minority Interest
0.70
-98.40%
43.68
-3.06%
45.06
-1.55%
45.77
Long Term Debt And Capital Lease Obligation
0.70
-55.63%
1.58
-32.80%
2.34
-22.29%
3.02
Long Term Capital Lease Obligation
0.70
-55.63%
1.58
-32.80%
2.34
-22.29%
3.02
Preferred Securities Outside Stock Equity
0.00
-100.00%
42.10
+0.00%
42.10
+0.00%
42.10
Stockholders Equity
-1.89
+95.50%
-42.06
-20.61%
-34.87
-48.84%
-23.43
Common Stock Equity
-5.07
+87.94%
-42.06
-20.61%
-34.87
-48.84%
-23.43
Capital Stock
3.18
+317668700.00%
0.00
-99.89%
0.00
+0.78%
0.00
Common Stock
0.00
+24100.00%
0.00
-99.89%
0.00
+0.78%
0.00
Preferred Stock
3.18
0.00
—
—
Share Issued
0.14
+2212.88%
0.01
+15.90%
0.01
+0.00%
0.01
Ordinary Shares Number
0.14
+2212.88%
0.01
+15.90%
0.01
+0.00%
0.01
Additional Paid In Capital
67.14
+6405.22%
1.03
+11.15%
0.93
+71.36%
0.54
Retained Earnings
-70.92
-64.58%
-43.09
-20.36%
-35.80
-49.35%
-23.97
Total Equity Gross Minority Interest
-1.89
+95.50%
-42.06
-20.61%
-34.87
-48.84%
-23.43
Total Capitalization
-1.89
+95.50%
-42.06
-20.61%
-34.87
-48.84%
-23.43
Working Capital
-3.69
-139.95%
-1.54
-126.00%
5.91
-66.57%
17.69
Invested Capital
-5.07
+87.77%
-41.46
-18.89%
-34.87
-48.84%
-23.43
Total Debt
1.58
-46.49%
2.94
-2.41%
3.02
-16.25%
3.60
Capital Lease Obligations
1.58
-32.80%
2.34
-22.29%
3.02
-16.25%
3.60
Net Tangible Assets
-1.89
+95.50%
-42.06
-20.61%
-34.87
-48.84%
-23.43
Tangible Book Value
-5.07
+87.94%
-42.06
-20.61%
-34.87
-48.84%
-23.43
Current Notes Payable
0.00
-100.00%
0.60
—
—
Derivative Product Liabilities
—
—
0.61
-5.71%
0.65
Interest Payable
0.00
-100.00%
0.03
—
—
Other Equity Interest
-1.30
—
—
—
Preferred Stock Equity
3.18
—
—
—
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-5.79
+50.55%
-11.71
-16.00%
-10.09
Cash Flow From Continuing Operating Activities
-5.79
+50.55%
-11.71
-16.00%
-10.09
Net Income From Continuing Operations
-7.29
+38.38%
-11.83
-11.28%
-10.63
Depreciation Amortization Depletion
1.12
+4.14%
1.07
+45.87%
0.74
Depreciation
1.12
+4.14%
1.07
+45.87%
0.74
Depreciation And Amortization
1.12
+4.14%
1.07
+45.87%
0.74
Other Non Cash Items
0.04
—
—
Stock Based Compensation
0.10
-74.57%
0.38
+32.44%
0.29
Operating Gains Losses
-0.29
-684.67%
-0.04
+96.23%
-0.98
Gain Loss On Investment Securities
-0.29
-684.67%
-0.04
+96.23%
-0.98
Change In Working Capital
0.54
+141.64%
-1.30
-363.45%
0.49
Change In Prepaid Assets
-0.11
-326.51%
0.05
-49.26%
0.10
Change In Payables And Accrued Expense
1.32
+273.99%
-0.76
-210.47%
0.69
Change In Accrued Expense
0.04
+106.39%
-0.69
-245.19%
0.48
Change In Payable
1.28
+1963.07%
-0.07
-132.40%
0.21
Change In Account Payable
1.28
+1963.07%
-0.07
-132.40%
0.21
Change In Other Current Liabilities
-0.67
-14.89%
-0.59
-98.63%
-0.29
Investing Cash Flow
—
-0.69
-13.33%
-0.61
Cash Flow From Continuing Investing Activities
—
-0.69
-13.33%
-0.61
Net PPE Purchase And Sale
—
-0.69
-13.33%
-0.61
Purchase Of PPE
—
-0.69
-13.33%
-0.61
Capital Expenditure
—
-0.69
-13.33%
-0.61
Financing Cash Flow
0.57
+10063.16%
0.01
-90.66%
0.06
Cash Flow From Continuing Financing Activities
0.57
+10063.16%
0.01
-90.66%
0.06
Net Issuance Payments Of Debt
0.61
—
—
Issuance Of Debt
0.61
—
—
Long Term Debt Issuance
0.61
—
—
Net Long Term Debt Issuance
0.61
—
—
Short Term Debt Issuance
0.00
—
—
Net Short Term Debt Issuance
0.00
—
—
Proceeds From Stock Option Exercised
0.01
+2.51%
0.01
-90.66%
0.06
Net Other Financing Charges
-0.04
—
—
Changes In Cash
-5.22
+57.91%
-12.40
-16.45%
-10.65
Beginning Cash Position
6.82
-64.51%
19.22
-35.65%
29.86
End Cash Position
1.60
-76.52%
6.82
-64.51%
19.22
Free Cash Flow
-5.79
+53.32%
-12.40
-15.85%
-10.71
Issuance Of Capital Stock
0.00
—
—
Net Preferred Stock Issuance
0.00
—
—
Preferred Stock Issuance
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category